 | |  | |  | |  | |  | |  |
|
October 7, 2007
A new report conducted by Ethiopia’s Federal
HIV/AIDS Control Office (FAPCO) reveals that new
HIV infections there have increased 26 percent
compared to data collected at the beginning of this
year.
In the first phase of the study, from November 2006
through January 2007, researchers found that
37,943 Ethiopians were HIV positive, representing
5.4 percent of the total population. The second
phase, which ended in August 2007, showed that
70,470 people (7.3 percent of the population) were
living with HIV.
While FAPCO’s Millennium AIDS Campaign aimed to
test 1.8 million Ethiopians from January through July
of this year, only 982,452 people were tested.
According to Dr. Yibeltal Assefa, health program
officer at HAPCO, 3 million testing kits have been
prepared for the new year.
A new report conducted by Ethiopia’s Federal
HIV/AIDS Control Office (FAPCO) reveals that new
HIV infections there have increased 26 percent
compared to data collected at the beginning of this
year.
In the first phase of the study, from November 2006
through January 2007, researchers found that
37,943 Ethiopians were HIV positive, representing
5.4 percent of the total population. The second
phase, which ended in August 2007, showed that
70,470 people (7.3 percent of the population) were
living with HIV.
While FAPCO’s Millennium AIDS Campaign aimed to
test 1.8 million Ethiopians from January through July
of this year, only 982,452 people were tested.
According to Dr. Yibeltal Assefa, health program
officer at HAPCO, 3 million testing kits have been
prepared for the new year.
|
October 8, 2007
This year’s crop of incoming college students may
have heard plenty about HIV throughout their lives—
but they still might not make prevention a personal
priority, NPR reports.
At a recent meeting at Howard University in
Washington, DC, UNAIDS director Dr. Peter Piot
urged students to become informed about the virus—
and to realize that the global AIDS epidemic is far
from over. He also addressed DC’s high HIV-
infection rate: One in 20 people there is HIV positive.
According to an American College Health
Association study, HIV prevalence among college
students last year was nearly equal to HIV
prevalence in the general population.
This year’s crop of incoming college students may
have heard plenty about HIV throughout their lives—
but they still might not make prevention a personal
priority, NPR reports.
At a recent meeting at Howard University in
Washington, DC, UNAIDS director Dr. Peter Piot
urged students to become informed about the virus—
and to realize that the global AIDS epidemic is far
from over. He also addressed DC’s high HIV-
infection rate: One in 20 people there is HIV positive.
According to an American College Health
Association study, HIV prevalence among college
students last year was nearly equal to HIV
prevalence in the general population.
More NEWS |
October 8, 2007
Asossa, October 8, 2007 (WIC) – The Benshangul-
Gumz State HIV/AIDS Prevention and Control Office
said it has allotted 10.5 million birr this fiscal year.
Monitoring and Evaluation Officer with the Office,
Jira Filate, told WIC today that the budget was
earmarked by the government and donor
organizations so as to undertake preventive works
that involve the community.
He said the budget would also enable to finalize and
furnish 11 health posts and eight VCT centers under
construction.
Besides, anti-retroviral drugs distribution center will
also be built and care would be provided for 4,000
HIV/AIDS orphans while financial and material
support as well as loan could be given to 7,200
people living with the virus, it was indicated.
Awareness raising education would be given to over
100,000 residents in the budget year, Jira said,
adding that youth, women and PLwHA associations
established to prevent HIV/AIDS will also be
strengthened.
The fund for the activities was raised by Global
Fund, World Bank, UNDP and the government, it
was learnt.
Asossa, October 8, 2007 (WIC) – The Benshangul-
Gumz State HIV/AIDS Prevention and Control Office
said it has allotted 10.5 million birr this fiscal year.
Monitoring and Evaluation Officer with the Office,
Jira Filate, told WIC today that the budget was
earmarked by the government and donor
organizations so as to undertake preventive works
that involve the community.
He said the budget would also enable to finalize and
furnish 11 health posts and eight VCT centers under
construction.
Besides, anti-retroviral drugs distribution center will
also be built and care would be provided for 4,000
HIV/AIDS orphans while financial and material
support as well as loan could be given to 7,200
people living with the virus, it was indicated.
Awareness raising education would be given to over
100,000 residents in the budget year, Jira said,
adding that youth, women and PLwHA associations
established to prevent HIV/AIDS will also be
strengthened.
The fund for the activities was raised by Global
Fund, World Bank, UNDP and the government, it
was learnt.
October 10, 2007
Gambella (ENA), October 10, 2007—The 3rd round
millennium anti-HIV/AIDS campaign was launched
yesterday in Gambella State, the State Health
Bureau said. Speaking at a two-day relevant
workshop, Bureau Deputy Head Can Galwak and
state Anti HIV/AIDS Campaign Coordinator James
Ball said over 10,450 people are expected to benefit
from the campaign. Efforts are being made to
enable 910 PLWHAs to take Anti-Retroviral drugs in
the same campaign, he added.
Gambella (ENA), October 10, 2007—The 3rd round
millennium anti-HIV/AIDS campaign was launched
yesterday in Gambella State, the State Health
Bureau said. Speaking at a two-day relevant
workshop, Bureau Deputy Head Can Galwak and
state Anti HIV/AIDS Campaign Coordinator James
Ball said over 10,450 people are expected to benefit
from the campaign. Efforts are being made to
enable 910 PLWHAs to take Anti-Retroviral drugs in
the same campaign, he added.
October 12, 2007
The U.S. Food and Drug Administration (FDA) has
granted approval to Merck’s Isentress (raltegravir),
the first of a new class of HIV drugs known as
integrase inhibitors. Isentress, at a dose of one 400
mg tablet twice a day, has been approved
specifically for use in combination with other
antiretrovirals (ARVs) to treat treatment-experienced
HIV-positive patients with resistance to multiple
ARVs.
The U.S. Food and Drug Administration (FDA) has
granted approval to Merck’s Isentress (raltegravir),
the first of a new class of HIV drugs known as
integrase inhibitors. Isentress, at a dose of one 400
mg tablet twice a day, has been approved
specifically for use in combination with other
antiretrovirals (ARVs) to treat treatment-experienced
HIV-positive patients with resistance to multiple
ARVs.
© 2007 Abesha Care Inc. All Right Reserved. office@abeshacare.org
October 20, 2007
Today, October 20, Haile Gebrselassie, 34, new
marathon world record holder, is in Detroit to
support a dinner raising funds for the Ethiopian
North American Health Professionals Association
(ENAHPA), an organization founded by Detroit
cardiac physician Dr. Ingida Asfaw, dedicated to
alleviating the severe health care crisis in Ethiopia.
Today, October 20, Haile Gebrselassie, 34, new
marathon world record holder, is in Detroit to
support a dinner raising funds for the Ethiopian
North American Health Professionals Association
(ENAHPA), an organization founded by Detroit
cardiac physician Dr. Ingida Asfaw, dedicated to
alleviating the severe health care crisis in Ethiopia.
| NEWS |
 | |  | |  | |  | |  | |  | |  | |  | |  |